Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery
- PMID: 10822300
- DOI: 10.1038/sj.gt.3301170
Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery
Abstract
Radioiodide concentrating activity in the thyroid, mediated by human Na+/I- symporter (hNIS), provides a mechanism for effective radioiodide treatment for patients who have invasive, recurrent, and metastatic thyroid cancers after total thyroidectomy. In an attempt to develop hNIS gene transfer for radioiodide therapy for patients with brain tumors, we have constructed recombinant adenoviruses, rAd-CMV-hNIS9 and rAd-CMV-FLhNIS, to express exogenous hNIS in U1240 and U1240Tag human glioma cells. U1240Tag differs from U1240 glioma cells in that it expresses the SV40 large T antigen oncoprotein. In both U1240 and U1240Tag cells, radioiodide uptake (RAIU) activity in the cells infected with rAd-CMV-hNIS9 or rAd-CMV-FLhNIS increases as the adenoviral MOI increases. The protein expression profile of hNIS in infected cells is generally in agreement with their RAIU activity profile. Although the expressed hNIS9 protein appeared to have a shorter half-life than FLhNIS, hNIS9 expression could be maintained by multiple infections in these cells. In addition, we show that hNIS can be expressed and function in a xenografted human glioma by intratumoral injection of rAd-CMV-hNIS9.
Similar articles
-
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.Gene Ther. 2002 Sep;9(17):1139-45. doi: 10.1038/sj.gt.3301787. Gene Ther. 2002. PMID: 12170377
-
Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.Cancer Biother Radiopharm. 2011 Aug;26(4):443-51. doi: 10.1089/cbr.2010.0908. Epub 2011 Jul 28. Cancer Biother Radiopharm. 2011. PMID: 21797672
-
Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.Oncol Rep. 2003 Jul-Aug;10(4):845-9. Oncol Rep. 2003. PMID: 12792733
-
Oncolytic adenoviral therapy for glioblastoma multiforme.Neurosurg Focus. 2006 Apr 15;20(4):E19. Neurosurg Focus. 2006. PMID: 16709024 Review.
-
A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.Curr Gene Ther. 2002 Dec;2(4):393-402. doi: 10.2174/1566523023347599. Curr Gene Ther. 2002. PMID: 12477251 Review.
Cited by
-
The status of gene therapy for brain tumors.Expert Opin Biol Ther. 2007 Feb;7(2):197-208. doi: 10.1517/14712598.7.2.197. Expert Opin Biol Ther. 2007. PMID: 17250458 Free PMC article. Review.
-
Periodontitis and diabetes interrelationships in rats: biochemical and histopathological variables.J Diabetes Metab Disord. 2019 May 16;18(1):163-172. doi: 10.1007/s40200-019-00403-4. eCollection 2019 Jun. J Diabetes Metab Disord. 2019. PMID: 31275887 Free PMC article.
-
Progress in gene therapy for prostate cancer.Front Oncol. 2012 Nov 19;2:172. doi: 10.3389/fonc.2012.00172. eCollection 2012. Front Oncol. 2012. PMID: 23181221 Free PMC article.
-
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.Mol Ther Oncolytics. 2021 Mar 10;21:98-109. doi: 10.1016/j.omto.2021.03.006. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 33981826 Free PMC article. Review.
-
The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus.J Periodontal Implant Sci. 2013 Apr;43(2):87-95. doi: 10.5051/jpis.2013.43.2.87. Epub 2013 Apr 30. J Periodontal Implant Sci. 2013. PMID: 23678392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical